DOCU shares climb 6.1% in a month with earnings and revenue growth fueled by rising demand for eSignature and its Intelligent Agreement Management platform.

News headlines DocuSign (DOCU) is gaining renewed interest following strong Q3 earnings and expansion into AI, despite a 26% drop in stock price over the past year. Analysts are assessing its ...

Clarity Pediatrics, the emerging telehealth leader reimagining pediatric chronic care, announced today $14.5M in Series A funding. The funding round was led by Jackson Square Ventures and welcomed new ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the double ...